|

Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid

RECRUITINGN/ASponsored by Washington University School of Medicine
Actively Recruiting
PhaseN/A
SponsorWashington University School of Medicine
Started2025-04-01
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06910670

Summary

The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Eligibility Criteria:

* Enrolled in the WU-PE-CGS study (IRB#202106129); that eligibility entails:

  * Diagnosis of cholangiocarcinoma
  * Diagnosis of multiple myeloma, must be African American
  * Diagnosis of colorectal cancer, must be African American and age 65 or older at time of diagnosis
* At least 18 years old.
* Able to understand an IRB-approved informed consent document and agree to participation
* Have access to a personal computer, tablet or mobile device

Conditions4

CancerCholangiocarcinomaColorectal CancerMultiple Myeloma

Locations1 site

Washington University School of Medicine
St Louis, Missouri, 63110
Erin Linnenbringer, Ph.D., MS314-747-1966elinnen@wustl.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.